Patents by Inventor Hideo Tomozane

Hideo Tomozane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyanopyridine derivative and use thereof as medicine
    Patent number: 7928126
    Abstract: A therapeutic drug for cancer containing a substance selected from the group consisting of a novel cyanopyridine derivative, a pharmaceutically acceptable salt, a hydrate, a water adduct and a solvate as an active ingredient can be provided.
    Type: Grant
    Filed: April 28, 2006
    Date of Patent: April 19, 2011
    Assignee: Mitsubishi Tanabe Pharma Corporation
    Inventors: Masahiko Morioka, Hiroshi Ikegami, Makoto Sakiyama, Masayuki Hayashi, Shinsuke Ooike, Yasuhiro Fujino, Daisuke Abe, Hideo Tomozane
  • Cyanopyridine derivative and use thereof as medicine
    Publication number: 20090292121
    Abstract: A therapeutic drug for cancer containing a substance selected from the group consisting of a novel cyanopyridine derivative, a pharmaceutically acceptable salt, a hydrate, a water adduct and a solvate as an active ingredient can be provided.
    Type: Application
    Filed: April 28, 2006
    Publication date: November 26, 2009
    Inventors: Masahiko Morioka, Hiroshi Ikegami, Makoto Sakiyama, Masayuki Hayashi, Shinsuke Ooike, Yasuhiro Fujino, Daisuke Abe, Hideo Tomozane
  • Benzylpiperidine compound
    Patent number: 7115635
    Abstract: The object of the present invention is to provide a compound having a treatment effect based on a chemokine inhibitory activity, which is satisfactory as a pharmaceutical product for oral administration. The present inventors have found that the following benzylpiperidine derivative (the formula (1)) has a chemokine inhibitory activity. Further intensive studies have resulted in successful enhancement of the chemokine inhibitory activity and stability in blood of the present compound, as well as the completion of the present invention. wherein each symbol is as defined in the specification.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: October 3, 2006
    Assignee: Mitsubishi Pharma Corporation
    Inventors: Masatoshi Kiuchi, Takanobu Kuroita, Hideo Tomozane, Shuuzou Takeda, Yoshihito Tanaka, Hidemitsu Higashi, Shigeki Kuwahara
  • Novel benzylpiperidine compound
    Publication number: 20040158071
    Abstract: The object of the present invention is to provide a compound having a treatment effect based on a chemokine inhibitory activity, which is satisfactory as a pharmaceutical product for oral administration.
    Type: Application
    Filed: December 15, 2003
    Publication date: August 12, 2004
    Inventors: Masatoshi Kiuchi, Takanobu Kurota, Hideo Tomozane, Shuuzou Takeda, Yoshihito Tanaka, Hidemitsu Higashi, Shigeki Kuwahara